Eptinezumab in chronic migraine and medication-overuse headache Presented ByProf. Hans-Christoph Diener, Medical Faculty of the University Duisburg-Essen, Germany TrialPhase 3, PROMISE-2 ConferenceEAN 2020 9 September, 2020 17:09
Eptinezumab reduces mean monthly migraine days TrialPhase 3, PROMISE ConferenceAAN 2019 30 July, 2019 21:35